Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update

Published:2022-09 Issue: Volume:239 Page:114542
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Engle Kritika,Kumar Gautam^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference179 articles.

1. The epigenomics of cancer;Jones;Cell,2007

2. Immunological aspects of cancer chemotherapy;Zitvogel;Nat. Rev. Immunol.,2008

3. MiRNAs and cancer;Visone;Am. J. Pathol.,2009

4. How cancer arises;Weinberg;Sci. Am.,1996

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance;European Journal of Medicinal Chemistry;2024-11

2. Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells;International Journal of Molecular Sciences;2024-09-08

3. Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer;Journal of Ethnopharmacology;2024-09

4. Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition;Molecules;2024-08-23

5. Proteogenomic characterization of pancreatic neuroendocrine tumors uncovers hypoxia and immune signatures in clinically aggressive subtypes;iScience;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP